MedTrace Logo

Probiotics for Prophylaxis of Postoperative Hirschsprungs Associated Enterocolitis

NCT02343562 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2018-01-30

No results posted yet for this study

Summary

Hirschsprungs Associated Enterocolitis (HAEC) with incidence up to 30% postoperatively. The objective of the trial is to prevent postoperative HAEC by using Probiotics.

Conditions

  • Hirschsprung Disease

Interventions

DIETARY_SUPPLEMENT

Probiotics

Probiotics in the form of sachet will be given twice daily for a period of at least 6 months during the trial period.

DIETARY_SUPPLEMENT

Placebo

Multivitamin off-the-counter.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Mahmoud MA Elfiky, M.D. · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02343562 on ClinicalTrials.gov